A Study of Single Dose of BL0175 in Postmenopausal Women
Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-21
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn the safety and PK of the single dose of BL0175 Injection in postmenopausal women and to compare that with a single dose of Fulvestrant Injection. The main questions it aims to answer are:
* What medical problems do participants have when using drug BL0175?
* How long can BL0175 remain in your blood? Participants will receive a single dose of drug BL0175 or a single dose of Fulvestrant Injection in a randomized method